Core Viewpoint - The lawsuit involving 39 defendants, including Gel Software, stems from a significant fraud case related to Zeda Yisheng, which has raised questions about the accountability of intermediary institutions in the capital market and the potential for redefining responsibility distribution in such cases [1][2][3]. Group 1: Background of the Case - Zeda Yisheng, a high-tech company that claimed to empower the pharmaceutical industry, was found to have inflated its revenue by 565 million yuan and profits by nearly 300 million yuan through fraudulent contracts and transactions from 2016 to 2021 [2][3]. - The company was forced to delist from the STAR Market in July 2023, becoming the first company to be delisted due to significant legal violations [2][3]. Group 2: Legal Proceedings - The three intermediary institutions involved in Zeda Yisheng's IPO, including Dongxing Securities, Tianjian Accounting, and Kangda Law Firm, collectively paid approximately 493 million yuan in compensation to investors and regulatory fines, prompting them to seek reverse compensation from the 39 partners involved in the fraudulent transactions [3][5]. - Gel Software is specifically noted for its involvement in two batches of transactions with Zeda Yisheng, which were deemed to lack commercial substance, contributing to inflated revenue of 13.3679 million yuan [4][5]. Group 3: Implications for the Industry - The lawsuit signifies a shift towards "full-chain accountability" in the capital market, where not only the listed companies and intermediary institutions but also their trading partners may face legal consequences for their involvement in fraudulent activities [6][7]. - The outcome of this case could set a precedent for how responsibility is allocated among various parties in financial fraud cases, potentially leading to more cautious business practices to avoid being implicated in similar schemes [6][7].